HS-10182, an EGFR Tyrosine Kinase Inhibitor, Increases Radiation Sensitivity in Non-Small Cell Lung Cancer With EGFR T790M Mutation

被引：0
|
作者：
Wang, Y. [1 ]
Chen, Y. [1 ]
Liu, N. [2 ]
Zhao, L. [3 ]
机构：
[1] Tianjin Med Univ, Canc Inst & Hosp, Tianjin, Peoples R China
[2] Tianjin Med Univ, Canc Inst & Hosp, Dept Radiotherapy Oncol, Tianjin, Peoples R China
[3] Tianjin Med Univ, Canc Hosp & Inst, Tianjin, Peoples R China
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2016年 / 96卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2016.06.1719
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3067
引用
收藏
页码：E433 / E433
页数：1
相关论文
共 50 条
  • [41] Resistant Patterns to Osimertinib in Non-Small Cell Lung Cancer Patients with Both T790M and Sensitizing EGFR Mutation
    Lee, J. C.
    Yang, S.
    Oh, D. K.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S806 - S807
  • [42] Primary concomitant EGFR T790M mutation predicted worse prognosis in non-small cell lung cancer patients
    Li, Hang
    Hu, Haichuan
    Wang, Rui
    Pan, Yunjian
    Wang, Lei
    Li, Yuan
    Zhang, Yang
    Ye, Ting
    Zhang, Yiliang
    Li, Bin
    Shen, Lei
    Sun, Yihua
    Chen, Haiquan
    ONCOTARGETS AND THERAPY, 2014, 7 : 513 - 524
  • [43] Clinical implication and usefulness of de novo EGFR T790M mutation in lung adenocarcinoma with EGFR-tyrosine kinase inhibitor sensitizing mutation
    Lee, Sang Hoon
    Kim, Eun Young
    Kim, Arum
    Chang, Yoon Soo
    CANCER BIOLOGY & THERAPY, 2020, 21 (08) : 741 - 748
  • [44] Non-Small Cell Lung Cancer with De Novo EGFR T790M Mutation: Clinical Features of 22 Cases
    Heo, Mi Hwa
    Kim, Hee Kyung
    Lee, Hansang
    Cho, Jinhyun
    Park, Juyoun
    Jeong, Su-Mi
    Sun, Jong-Mu
    Lee, Se-Hoon
    Ahn, Jin Seok
    Park, Keunchil
    Ahn, Myung-Ju
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1237 - S1238
  • [45] Different characteristics and survival in non-small cell lung cancer patients with primary and acquired EGFR T790M mutation
    Wang, Shuyuan
    Yan, Bo
    Zhang, Yanwei
    Xu, Jianlin
    Qiao, Rong
    Dong, Yu
    Zhang, Bo
    Zhao, Yiming
    Zhang, Lele
    Qian, Jie
    Lu, Jun
    Zhao, Ruiying
    Han, Baohui
    INTERNATIONAL JOURNAL OF CANCER, 2019, 144 (11) : 2880 - 2886
  • [46] Plasma ctDNA Analysis for Detection of the EGFR T790M Mutation in Patients with Advanced Non-Small Cell Lung Cancer
    Jenkins, Suzanne
    Yang, James C-H.
    Ramalingam, Suresh S.
    Yu, Karen
    Patel, Sabina
    Weston, Susie
    Hodge, Rachel
    Cantarini, Mireille
    Janne, Pasi A.
    Mitsudomi, Tetsuya
    Goss, Glenwood D.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (07) : 1061 - 1070
  • [47] The correlation between the abundance of EGFR T790M mutation and osimertinib response in advanced non-small cell lung cancer
    Pan, Guoqiang
    Chen, Kaiyan
    Yu, Xiaoqing
    Sheng, Jiamin
    Fan, Yun
    TRANSLATIONAL CANCER RESEARCH, 2021, 10 (06) : 2895 - 2905
  • [48] Third-generation inhibitors targeting EGFR T790M mutation in advanced non-small cell lung cancer
    Shuhang Wang
    Shundong Cang
    Delong Liu
    Journal of Hematology & Oncology, 9
  • [49] Third-generation inhibitors targeting EGFR T790M mutation in advanced non-small cell lung cancer
    Wang, Shuhang
    Cang, Shundong
    Liu, Delong
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2016, 9
  • [50] Evidence-based best practices for EGFR and EGFR T790M mutation testing in non-small cell lung cancer (NSCLC) in the UK
    Welch, L.
    Butler, R.
    Taniere, P.
    Thompson, L.
    Oniscu, A.
    Clarke, C.
    Burghel, G.
    Collins, N.
    Timm, L.
    LUNG CANCER, 2019, 127 : S14 - S14
12345